<DOC>
	<DOC>NCT01493726</DOC>
	<brief_summary>This study will determine the pharmacokinetics (PK), safety, and tolerability of ALKS 9072 (also known as ALKS 9070) after 4 monthly doses in adults with chronic stable schizophrenia.</brief_summary>
	<brief_title>A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia</brief_title>
	<detailed_description>Three active treatment groups and a placebo group are planned. Randomization will be sequential by dose level across the sites with placebo assignments randomly inserted. Each subject's participation will be approximately 8 months, including screening, treatment period, and a 3-month follow-up period.</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Diagnosis of chronic schizophrenia that is clinically stable Body mass index (BMI) between 18.5 and 35.0 kg/m2, inclusive Stable antipsychotic medication regimen for &gt;/= 2 months before Screening Be willing and able to be confined to an inpatient clinical research unit for a total of 37 days during the course of the study Aripiprazole used within 30 days before Screening History of intolerance of or allergy or hypersensitivity to aripiprazole, its excipients, other antipsychotic agents, or INTRALIPID (including peanuts, soy, egg, or glycerol) Current diagnosis of an Axis I disorder other than schizophrenia History of seizure disorder or any condition associated with seizures History of neuroleptic malignant syndrome (NMS) Positive test result for HIV, hepatitis B surface antigen, or antihepatitis C antibodies Received medication by IM injection within 30 days before Screening Monoamine oxidase inhibitors (eg, phenelzine, tranylcypromine, selegiline) used within 30 days before Screening DSMIVTR diagnosis of alcohol or substance dependence, with the exception of nicotine or caffeine dependence within 12 months before Screening Donation of blood or blood components within 4 weeks before Screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>